mitomycin has been researched along with Coronary Artery Disease in 1 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awad-Allah, MAA | 1 |
| Mousa, AS | 1 |
| Ashour, DM | 1 |
1 other study available for mitomycin and Coronary Artery Disease
| Article | Year |
|---|---|
The outcomes of a low-cost, non-valved glaucoma drainage device using mitomycin-C: 1-year results.
Topics: Coronary Angiography; Coronary Artery Disease; Follow-Up Studies; Glaucoma Drainage Implants; Humans | 2023 |